Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic Development.

MLA

Yap, Timothy A., et al. “Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic Development.” American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, vol. 43, June 2023, p. e390738. EBSCOhost, https://doi.org/10.1200/EDBK_390738.

APA

Yap, T. A., Stadler, Z. K., Stout, L. A., & Schneider, B. P. (2023). Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic Development. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, 43, e390738. https://doi.org/10.1200/EDBK_390738

Chicago

Yap, Timothy A, Zsofia K Stadler, Leigh Anne Stout, and Bryan P Schneider. 2023. “Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic Development.” American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 43 (June): e390738. doi:10.1200/EDBK_390738.